GenOdyssee SA Announces Research Partnership with Baxter AG
25 Oct 2006 -
GenOdyssee S.A., a biotechnology company dedicated to the discovery of novel protein therapeutic products, has entered into a research and development cooperation agreement with Baxter AG. GenOdyssee will use its unique intellectual property position in the field of protein therapeutics, as well as its proprietary technology and integrated processes, in the discovery of novel blood clotting factors.
Under the agreement, any resulting commercially viable products will be developed and brought to market by Baxter AG.
Additional information
Baxter International Inc. Deerfield, IL, United States of America
Top
Contact
Print version
Send article
RSS feed